Global business leader Adam Schechter became Chief Executive Officer of Labcorp in November 2019 and Chairman of the Board in May 2020. Prior to that, he was named Lead Independent Director in January 2019 after serving as a director of the company since 2013.
Before joining Labcorp, Adam held a variety of senior leadership positions at Merck & Co., Inc. He was Executive Vice President and President of Merck’s Global Human Health Division from 2010 to 2018, leading the company’s worldwide pharmaceutical and vaccine businesses. In this role, he was also a member of Merck’s executive committee.
Prior to becoming President, Global Human Health, Adam served as President of Merck’s global pharmaceutical business from 2007 to 2010. His extensive experience at Merck also included global and U.S.-focused leadership roles spanning sales, marketing and managed markets, as well as business and product development.
Adam has been a Board Member for DaVita Inc. since 2022, and he serves on the Board for Water.org. He also serves as the American Clinical Laboratory Association (ACLA) Board Vice-Chair and a member of the Corporate Advisory Council for the National Alliance for Hispanic Health. Previously, he served on the Boards of the European Federation of Pharmaceutical Industries and Associations (EFPIA), where he led the Policy and Access Committee, the Healthcare Leadership Council and the Merial Animal Health Company.
Adam holds a Bachelor of Science in biology and an honorary doctor of humane letters degree from La Salle University in Philadelphia, Pennsylvania.
What is Adam H. Schechter's net worth?
The estimated net worth of Adam H. Schechter is at least $20.15 million as of February 11th, 2025. Mr. Schechter owns 86,445 shares of Laboratory Co. of America stock worth more than $20,154,220 as of March 26th. This net worth estimate does not reflect any other investments that Mr. Schechter may own. Additionally, Mr. Schechter receives an annual salary of $4,660,000.00 as Chairman, President, and CEO at Laboratory Co. of America. Learn More about Adam H. Schechter's net worth.
How old is Adam H. Schechter?
What is Adam H. Schechter's salary?
How do I contact Adam H. Schechter?
The corporate mailing address for Mr. Schechter and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at investor@labcorp.com. Learn More on Adam H. Schechter's contact information.
Has Adam H. Schechter been buying or selling shares of Laboratory Co. of America?
During the last quarter, Adam H. Schechter has sold $1,497,319.02 of Laboratory Co. of America stock. Most recently, Adam H. Schechter sold 6,121 shares of the business's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $244.62, for a transaction totalling $1,497,319.02. Following the completion of the sale, the chief executive officer now directly owns 86,445 shares of the company's stock, valued at $21,146,175.90. Learn More on Adam H. Schechter's trading history.
Who are Laboratory Co. of America's active insiders?
Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Lance Berberian (EVP), Brian Caveney (EVP), Jonathan DiVincenzo (EVP and President, Central Laboratories and International), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Adam Schechter (Chairman, President, and CEO), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.
Are insiders buying or selling shares of Laboratory Co. of America?
During the last year, insiders at the medical research company sold shares 23 times. They sold a total of 87,220 shares worth more than $20,163,144.89. The most recent insider tranaction occured on March, 5th when Director Kerrii B Anderson sold 500 shares worth more than $127,815.00. Insiders at Laboratory Co. of America own 0.9% of the company.
Learn More about insider trades at Laboratory Co. of America. Information on this page was last updated on 3/5/2025.
